• Оценка терапевтического эффекта прутняка обыкновенного (Vitex agnus castus, BNO 1095) при симптомах предменструального синдрома умеренной и тяжелой степени у женщин в Китае
ru К содержанию

Оценка терапевтического эффекта прутняка обыкновенного (Vitex agnus castus, BNO 1095) при симптомах предменструального синдрома умеренной и тяжелой степени у женщин в Китае

HEALTH OF WOMAN. 2019.5(141): 17–21

Linlin MA, Shouqing LIN, Rong CHEN, Ying ZHANG, Fengling CHEN, Xiuli WANG
Пекинский медицинский университет, Китайская академия медицинских наук, г. Пекин, Китай
|Родильный дом и детская больница района Пингу в г. Пекин, Китай|
Australian and New Zealand Journal of Obstetrics and Gynaecology 2010; 50: 189–193. DOI:10.1111/j.1479-828X.2010.01137.x

      СПИСОК ЛИТЕРАТУРЫ

Johnson SR, McChesney C, Bean JA. Epidemiology of premenstrual symptoms in a nonclinical sample. I. Prevalence, natural history and help-seeking behavior. J Reprod Med 1988; 33: 340–346.

Singh BB, Berman BM, Simpson RL, Annchild A. Incidence of premenstrual symptome and remedy usage: a national probability sample study. Altern Ther Health Med 1998; 4: 75–79.

Zhao G, Wang L, Qu C. Prevalence of premenstrual syndrome in reproductive women and its influential factors. Clin J Obstet Gynecol 1998; 33: 222–224.

Qiao M, Zhang Z, Xu X, Han X, Ci Y, Ye Q. Epidemiological survey on syndromes distribution in PMS. Chin J Basic Med Tradit Chin Med 1997; 3: 31–33.

Steiner M. Premenstrual syndrome and premenstrual dysphoric disorder: guidelines of management. J Psychiatry Neurosci 2000; 45: 459–468.

Keye WR Jr. General evaluation of premenstrual symptoms. Clin Obstet Gynecol 1987; 30: 396–407.

Mortola JF. Issues in the diagnosis and research of premenstrual syndrome. Clin Obstet Gynecol 1992; 35: 587–598.

Ramcharan S, Love EJ, Fick GH, Goldfien A. The epidemiology of premenstrual symptoms in a populationbased sample of 2650 urban women: attributable risk and risk factors. J Clin Epidemiol 1992; 45: 377–392.

Angst J, Sellaro R, Merikangas KR, Endicott J. The epidemiology of perimenstrual psychological symptoms. Acta Psychiatr Scand 2001; 104: 110–116.

KiIicdag EB, Tarim E, Bagis T et al. Fructus agni casti and bromocriptine for treatment of hyperprolactinemia and mastalgia. Int J Gynaecol Obstet 2004; 85: 292–293.

Wuttke W, Gorkow C, Jarry H. Dopaminergic compounds in Vitex agnus castus. In: Loew RN, Darmstadt D, eds. Phytopharmaka in Forschung und klinischer Anwendung. Heidelberg: Steinkopff Verlag, 1995; 81–91.

Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective,randomised, placebo controlled study. BMJ 2001; 322: 134–137.

Halaska M, Beles P, Gorkow C, Sieder C. Treatment of ciclical mastalgia with a solution containing a Vitex agnus castus extract: results of a placebo-controlled double-blind study. Breast 1999; 8: 175–181.

Atmaca M, Kumru S, Tezcan E. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder. Hum Psychopharmacol Clin Exp 2003; 18:191–195.

Lauritzen Ch, Reuter HD, Repges R, BЁ ohnert KJ, Schmidt U. Treatment of premenstrual tension syndrome with Vitex agnus castus. Controlled, double-blind study vs. pyridoxine. Phytomedicine 1997; 4: 183–189.

He Z, Chen R, Zhou Y et al. Treatment for premenstrual syndrome with Vitex agnus castus: a prospective,randomized, multi-center placebo controlled study in China. Maturitas 2009; 63: 99–103.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Text Revision ed. Washington: American Psychiatric Association, 2000; 771–774.

Steiner M, Haskett RF, Carroll BJ. Premenstrual syndrome: the development of research diagnostic criteria and new rating scales. Acta Psychiatr Scand 1980; 62: 177–190.

Thys-Jaccobs S, Alvir J, Fratarcangelo P. Assessment and rating instrument: comparative analysis of three PMS assessment instruments – the identification of premenstrual syndrome with core symptoms. Psychopharmacol Bull 1995; 31: 389–396.

Freeman EW, Rickels K. Characteristics of placebo responses in medical treatment of premenstrual syndrome. Am J Psychiatry 1999; 156: 1403–1408.

Ernst-Gerhard L, Hartmut S, Normann B. Treatment of premenstrual syndrome with a phytopharmaceutical formulation containing Vitex agnus castus. J Women’s Health Gend Based Med 2000; 9: 315–320.

Liu H, Chen R, Lin S-q, Wang X-l, Chen Y. The study of pattern of symptom expression in moderate to severe premenstrual syndrome. Chin J Pract Gynecol Obstet 2009; 25:514–516.